SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Cardiogenesis (cgcp) -- Ignore unavailable to you. Want to Upgrade?

To: John Martin who wrote (18)10/22/1997 8:36:00 PM
From: DCOS  Respond to of 66
 
Thank you for the input. I personally like GDT. They have a very strong product pipeline and the fundaments should continue to improve with the release of the stent.



To: John Martin who wrote (18)3/16/1998 3:55:00 AM
From: Cook  Read Replies (1) | Respond to of 66
 
Perhaps the lack of news in the past few months has been due to a lack of activity at the company. I'm under the impression that, stopped in the US, they have concentrated more on Europe. It appears that the clinical trials there are proceeding slowly as well.
Any feeling on how long they can continue without a further injection of outside funds?


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News